Exploring the Median Effective Dose of Ciprofol for Anesthesia Induction in Elderly Patients: Impact of Frailty on ED50
Jingjing Yuan,Zenghui Liang,Muhoza Geoffrey,Yanle Xie,Shuhan Chen,Jing Liu,Yuzhong Xia,Huixin Li,Yanling Zhao,Yuanyuan Mao,Na Xing,Jianjun Yang,Zhongyu Wang,Fei Xing
DOI: https://doi.org/10.2147/dddt.s453486
IF: 4.3188
2024-04-04
Drug Design Development and Therapy
Abstract:Jingjing Yuan, 1, 2, &ast Zenghui Liang, 1, &ast Muhoza Bertrand Geoffrey, 1 Yanle Xie, 1, 2 Shuhan Chen, 1, 2 Jing Liu, 1, 2 Yuzhong Xia, 1 Huixin Li, 1 Yanling Zhao, 1 Yuanyuan Mao, 1, 2 Na Xing, 1, 2 Jianjun Yang, 1, 2 Zhongyu Wang, 1 Fei Xing 1, 2 1 Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, People's Republic of China; 2 Henan Province International Joint Laboratory of Pain, Cognition and Emotion, Zhengzhou, Henan Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fei Xing; Zhongyu Wang, Department of Anesthesiology, Pain and Perioperative Medicine, the First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road Erqi District, Zhengzhou City, Henan Province, People's Republic of China, Tel +86-15936275656, Email ; Purpose: Explore the median effective dose of ciprofol for inducing loss of consciousness in elderly patients and investigate how frailty influences the ED 50 of ciprofol in elderly patients. Patients and Methods: A total of 26 non-frail patients and 28 frail patients aged 65– 78 years, with BMI ranging from 15 to 28 kg/m 2 , and classified as ASA grade II or III were selected. Patients were divided into two groups according to frailty: non-frail patients (CFS< 4), frail patients (CFS≥ 4). With an initial dose of 0.3 mg/kg for elderly non-frail patients and 0.25 mg/kg for elderly frail patients, using the up-and-down Dixon method, and the next patient's dose was dependent on the previous patient's response. Demographic information, heart rate (HR), oxygen saturation (SpO 2 ), mean blood pressure (MBP), and bispectral index (BIS) were recorded every 30 seconds, starting from the initiation of drug administration and continuing up to 3 minutes post-administration. Additionally, the total ciprofol dosage during induction, occurrences of hypotension, bradycardia, respiratory depression, and injection pain were recorded. Results: The calculated ED 50 (95% confidence interval [CI]) and ED 95 (95% CI) values for ciprofol-induced loss of consciousness were as follows: 0.267 mg/kg (95% CI 0.250– 0.284) and 0.301 mg/kg (95% CI 0.284– 0.397) for elderly non-frail patients; and 0.263 mg/kg (95% CI 0.244– 0.281) and 0.302 mg/kg (95% CI 0.283– 0.412) for elderly frail patients. Importantly, no patients reported intravenous injection pain, required treatment for hypotension, or experienced significant bradycardia. Conclusion: Frailty among elderly patients does not exert a notable impact on the median effective dose of ciprofol for anesthesia induction. Our findings suggest that anesthesiologists may forego the necessity of dosage adjustments when administering ciprofol for anesthesia induction in elderly frail patients. Keywords: ciprofol, median effective dose, elderly patients, frailty, loss of consciousness With the continuous growth of the global population and improvements in living standards, an increasing number of elderly individuals are opting for surgical interventions. However, due to age-related physiological changes, elderly patients exhibit higher sensitivity to anesthesia drugs. 1 Consequently, during general anesthesia, elderly patients typically receive lower doses of anesthesia drugs compared to their younger counterparts to minimize the occurrence of potential side effects such as respiratory arrest and bradycardia. 2 Simutaneously, surgical frailty, as a multidimensional state accumulating age and disease-related deficits in elderly patients, leads to a reduction in their physiological reserves. Frail patients often demonstrate decreased tolerance to stressors, resulting in a diminished ability to adapt to adverse outcomes. 3 Changes in pharmacokinetic and pharmacodynamics, such as decreased albumin levels and altered activity of ATP-gated potassium channels, may impact the sensitivity of frail patients to anesthetic drugs. 4,5 In the process of anesthesia induction, propofol typically plays a crucial role. Propofol, acting as a modulator and agonist of γ-aminobutyric acid (GABA) receptors, 6,7 exerts its sedative and general anesthetic effects by enhancing central inhibitory GABA neurotransmission. However, propofol has known limitations, including significant inhibition of the circulatory system, the tendency to cause hypotension and hemodynamic fluctuations -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal